FDA Class II · Drug · July 15, 2026
Azacitidine for Injection 100mg/Vial recall — Reliance Life Sciences Private Limited
Lack of Sterility Assurance
Official ID D-0674-2026 · Official record ↗
Reliance Life Sciences Private recalls
4 recent recalls on record for Reliance Life Sciences Private in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.
Models with recalls
Azacitidine for Injection 100mg/Vial (1)Bortezomib for Injection 3 (1)Pemetrexed for Injection 100mg/Vial (1)Pemetrexed for Injection 500mg/Vial (1)
All Reliance Life Sciences Private recalls
FDA Class II · Drug · July 15, 2026
Bortezomib for Injection 3 recall — Reliance Life Sciences Private Limited
Lack of Sterility Assurance
Official ID D-0673-2026 · Official record ↗
FDA Class II · Drug · July 15, 2026
Pemetrexed for Injection 500mg/Vial recall — Reliance Life Sciences Private Limited
Lack of Sterility Assurance
Official ID D-0672-2026 · Official record ↗
FDA Class II · Drug · July 15, 2026
Pemetrexed for Injection 100mg/Vial recall — Reliance Life Sciences Private Limited
Lack of Sterility Assurance
Official ID D-0671-2026 · Official record ↗
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & egg products ↗ (not yet aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.